AU1656799A - Cationic drugs encapsulated in anionic liposomes - Google Patents

Cationic drugs encapsulated in anionic liposomes

Info

Publication number
AU1656799A
AU1656799A AU16567/99A AU1656799A AU1656799A AU 1656799 A AU1656799 A AU 1656799A AU 16567/99 A AU16567/99 A AU 16567/99A AU 1656799 A AU1656799 A AU 1656799A AU 1656799 A AU1656799 A AU 1656799A
Authority
AU
Australia
Prior art keywords
anionic liposomes
drugs encapsulated
cationic drugs
cationic
encapsulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16567/99A
Inventor
Peter Lutwyche
Murray S Webb
David J. Wiseman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inex Pharmaceuticals Corp
Original Assignee
Inex Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inex Pharmaceuticals Corp filed Critical Inex Pharmaceuticals Corp
Publication of AU1656799A publication Critical patent/AU1656799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU16567/99A 1997-12-12 1998-12-10 Cationic drugs encapsulated in anionic liposomes Abandoned AU1656799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6935997P 1997-12-12 1997-12-12
US60069359 1997-12-12
PCT/CA1998/001154 WO1999030686A1 (en) 1997-12-12 1998-12-10 Cationic drugs encapsulated in anionic liposomes

Publications (1)

Publication Number Publication Date
AU1656799A true AU1656799A (en) 1999-07-05

Family

ID=22088458

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16567/99A Abandoned AU1656799A (en) 1997-12-12 1998-12-10 Cationic drugs encapsulated in anionic liposomes

Country Status (2)

Country Link
AU (1) AU1656799A (en)
WO (1) WO1999030686A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
SI1077722T1 (en) 1998-05-22 2007-02-28 Ottawa Health Research Inst Methods and products for inducing mucosal immunity
PT1581236E (en) * 2002-10-29 2013-12-24 Insmed Inc Sustained release of antiinfectives
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
EP3067046B1 (en) 2005-12-08 2020-03-25 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
EP2123258A1 (en) 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery
DK177532B1 (en) 2009-09-17 2013-09-08 Bio Bedst Aps Medical use of sPLA2 hydrolysable liposomes
EP2717856B1 (en) * 2011-05-10 2016-11-23 The Penn State Research Foundation Ceramide anionic liposome compositions
SI2852391T1 (en) 2012-05-21 2022-04-29 Insmed Incorporated Systems for treating pulmonary infections
CA2891487A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
DK3466432T3 (en) 2014-05-15 2020-09-28 Insmed Inc PROCEDURES FOR THE TREATMENT OF PULMONAL NON-TUBERCULOSE MICOBACTERIAL INFECTIONS
CN109996809A (en) 2016-11-14 2019-07-09 诺华股份有限公司 Composition relevant to fusogenic protein MINION, method and therapeutical uses
AU2017258901A1 (en) 2016-12-30 2018-07-19 Allarity Therapeutics Europe ApS Methods for predicting drug responsiveness in cancer patients
GB201718631D0 (en) * 2017-11-10 2017-12-27 Pci Biotech As Method
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885613A (en) * 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
WO1997038010A2 (en) * 1996-04-11 1997-10-16 The University Of British Columbia Fusogenic liposomes

Also Published As

Publication number Publication date
WO1999030686A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
AU1656799A (en) Cationic drugs encapsulated in anionic liposomes
IL131259A0 (en) Topical drug preparations
AU6687998A (en) Oligomeric cationic lipids
AU9394498A (en) Ophthalmic composition including a cationic glycoside and an anionic therapeuticagent
AU8938098A (en) Liposomes containing oligonucleotides
PL340337A1 (en) Drugs
EP0750910A4 (en) Liposome preparation
AU8695698A (en) Pharmacologic drug combination in vagal-induced asystole
AU5387898A (en) Pharmaceutical agents
AU6729198A (en) Cosmetic preparations
AU7471194A (en) Cationic amphiphiles
AU2582399A (en) Liposome fusion and delivery vehicle
AU6846898A (en) Packaging and packaging machines therefor
AU7454698A (en) Improvement in medicament administration system
GB9702021D0 (en) Medicaments
AU2976897A (en) Multiple-unit type prolonged action drug preparation
GB9718791D0 (en) Medicaments
AU4090299A (en) Liposomal delivery complex
ZA982073B (en) Pharmaceutical preparation
AU9430798A (en) Shellac-containing cosmetic product
AU4001297A (en) Capsule
AU7830498A (en) Instant yogurt preparation
AU6793598A (en) Glycosylceramide-containing liposomes
AU2316997A (en) Liposomal delivery system
AU3265895A (en) Liposome preparation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase